Quantcast

Characterizing Antibody Responses to Plasmodium vivax and Plasmodium falciparum Antigens in India Using Genome-Scale Protein Microarrays.

Research paper by Swapna S Uplekar, Pavitra Nagesh PN Rao, Lalitha L Ramanathapuram, Vikky V Awasthi, Kalpana K Verma, Patrick P Sutton, Syed Zeeshan SZ Ali, Ankita A Patel, Sri Lakshmi Priya SL G, Sangamithra S Ravishankaran, Nisha N Desai, Nikunj N Tandel, Sandhya S Choubey, Punam P Barla, Deena D Kanagaraj, et al.

Indexed on: 25 Jan '17Published on: 25 Jan '17Published in: PLoS neglected tropical diseases



Abstract

Understanding naturally acquired immune responses to Plasmodium in India is key to improving malaria surveillance and diagnostic tools. Here we describe serological profiling of immune responses at three sites in India by probing protein microarrays consisting of 515 Plasmodium vivax and 500 Plasmodium falciparum proteins with 353 plasma samples. A total of 236 malaria-positive (symptomatic and asymptomatic) plasma samples and 117 malaria-negative samples were collected at three field sites in Raurkela, Nadiad, and Chennai. Indian samples showed significant seroreactivity to 265 P. vivax and 373 P. falciparum antigens, but overall seroreactivity to P. vivax antigens was lower compared to P. falciparum antigens. We identified the most immunogenic antigens of both Plasmodium species that were recognized at all three sites in India, as well as P. falciparum antigens that were associated with asymptomatic malaria. This is the first genome-scale analysis of serological responses to the two major species of malaria parasite in India. The range of immune responses characterized in different endemic settings argues for targeted surveillance approaches tailored to the diverse epidemiology of malaria across the world.

More like this: